Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cidara Therapeutics

46.84
+1.894.20%
Pre-market: 46.980.1400+0.30%08:36 EDT
Volume:3.48M
Turnover:166.99M
Market Cap:607.51M
PE:-1.75
High:56.83
Open:49.71
Low:43.04
Close:44.95
Loading ...
Jul 27, 2022

Major Issues Report

8-K - Current report
Jul 07, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities